Thank you for your interest. The I-MOVE+ project (2015-2018) is over, and this website will no longer be updated. However, activities to monitor vaccine effectiveness in Europe are ongoing and can be found on the I-MOVE and SpiDnet websites for influenza (coming soon) and pneumococcal vaccines (https://sites.google.com/a/epiconcept.fr/ipd-surveillance/) With contributions from all work packages leaders, EpiConcept will lead Management and Communication to disseminate the project results and progress and Scientific Coordination. The I-MOVE+ Excecutive Board is the supervisory body for the execution of the Project. The EB members are the leaders of WP1, WP2, WP3, WP4 and WP5. THe EB board reports to the Scientific Committee-Steering Committee (SC-ST). The SC-ST is the ultimate decision-making body of the I-MOVE+ Consortium. The SC-ST is constituted by a representative of each of the I-MOVE+ beneficiaries. Leader: EpiConcept Access to restricted area for Work Package 1 Access to the summary I-MOVE+ first Scientific Meeting Access to objectives WP3, WP4, WP5 technical meetings, 20-21 Sept 2016 |
I-MOVE+ NewsThank you for your interest. The I-MOVE+ project (2015-2018) is over, and this website will no longer be updated. However, activities to monitor vaccine effectiveness in Europe are ongoing and can be found on the I-MOVE and SpiDnet websites for influenza (coming soon) and pneumococcal vaccines https://sites.google.com/a/epiconcept.fr/ipd-surveillance/  |
|